Search results for "VIRUS DISEASE"

showing 10 items of 1907 documents

Reliability of wastewater analysis for monitoring COVID-19 incidence revealed by a long-term follow-up study

2021

Background Wastewater-based epidemiology has been used for monitoring human activities and waterborne pathogens. Although wastewaters can also be used for tracking SARS-CoV-2 at the population level, the reliability of this approach remains to be established, especially for early warning of outbreaks. Methods We collected 377 samples from different treatment plants processing wastewaters of >1 million inhabitants in Valencia, Spain, between April 2020 and March 2021. Samples were cleaned, concentrated, and subjected to RT-qPCR to determine SARS-CoV-2 concentrations. These data were compared with cumulative disease notification rates over 7 and 14 day periods. Results We amplified SARS-CoV-2…

medicine.medical_specialtyVeterinary medicineCoronavirus disease 2019 (COVID-19)Competing interestsPopulation levelSARS-CoV-2Long term follow upIncidence (epidemiology)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)epidemiological surveillancepublic healthOutbreakLitervirusGeneral MedicineBiologyAsymptomaticMicrobiologyQR1-502wastewater-based epidemiologyWastewaterEpidemiologymedicinemedicine.symptom
researchProduct

A Combined Multidisciplinary Intervention for Health Promotion in the Workplace: A Pilot Study

2021

The aim of this study was to assess the effects of a joint health promotion intervention on a cohort of healthcare workers (HCWs) who had at least one cardiovascular risk factor. The HCWs were assessed at three different times, i.e., time zero (T0), after 6 months (T6), and after 12 months (T12). The following parameters were measured at a medical examination: physical activity, blood pressure, waist circumference, body mass index (BMI), routine laboratory tests, plicometric analysis, work ability index (WAI), and body image dissatisfaction (BID). Among the 447 HCWs, 38 HCWs were included in the study; 45% (n = 17) were male. At T12, the average blood pressure, waist/hip ratio (WHR) index, …

medicine.medical_specialtyWaistMediterranean diethealth care facilities manpower and serviceseducationlcsh:Medicine030209 endocrinology & metabolismArticle03 medical and health sciences0302 clinical medicineWorkplace health promotionMediterranean dietHealth careMedicinecardiovascular risk factorbody image dissatisfaction (BID)030212 general & internal medicineRisk factorbusiness.industryhealthcare workerslcsh:Rvirus diseasesGeneral Medicinework ability index (WAI)Health promotionworkplace health promotion; healthcare workers; cardiovascular risk factor; work ability index (WAI); Mediterranean diet; body image dissatisfaction (BID)CohortHealthcare workerPhysical therapyworkplace health promotionbusinessBody mass indexJournal of Clinical Medicine
researchProduct

Treatment of chronic hepatitis C in hemodialysis patients

2008

Hepatitis C virus (HCV) infection is especially problematic in patients with end-stage renal disease (ESRD) who are undergoing hemodialysis. Rates of HCV infection are higher among hemodialysis patients than in the general population, and several routes of transmission are thought to stem from the dialysis unit. Management of chronic hepatitis C is also more complicated in hemodialysis patients because of altered pharmacokinetics and a predisposition for drug-related toxicity, particularly ribavirin-induced anemia. Clinical trials of patients with chronic hepatitis C and healthy, functioning kidney grafts are rare because of the inherent dangers of graft rejection. As a result, most studies…

medicine.medical_specialtyWaiting ListsHepatitis C virusmedicine.medical_treatmentPopulationInterferon alpha-2medicine.disease_causeAntiviral AgentsPolyethylene Glycolschemistry.chemical_compoundRenal DialysisInternal medicinePrevalencemedicineHumanseducationInterferon alfaeducation.field_of_studyHepatologybusiness.industryRibavirinInterferon-alphavirus diseasesHepatitis CHepatitis C ChronicHepatologymedicine.diseaseKidney TransplantationRecombinant Proteinsdigestive system diseasesSurgeryTolerabilitychemistryKidney Failure ChronicHemodialysisbusinessmedicine.drugHepatology
researchProduct

SARS-CoV-2 RNA load in the lower respiratory tract, viral RNAemia and N-antigenemia in critically ill adult COVID-19 patients: relationship with biom…

2021

ABSTRACTBackgroundLittle is known about the comparative kinetics of SARS-CoV-RNA load in the lower respiratory tract and in blood compartment in patients admitted to the intensive care unit, and how these relate to biomarkers of COVID-19 severity.MethodsSeventy-three consecutive critically ill COVID-19 patients (median age, 65 years) were recruited. Serial lower respiratory tract (n=165) and plasma (n=340) specimens were collected. RT-PCR and lateral flow immunochromatography assay were used for SARS-CoV-2 RNA quantitation and N protein detection in plasma, respectively. Serum levels of inflammatory and tissue-damage biomarkers in paired specimens were analyzed.ResultsSARS-CoV-RNA was detec…

medicine.medical_specialtybiologyCoronavirus disease 2019 (COVID-19)business.industryCritically illSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)RNAIntensive care unitGastroenterologylaw.inventionFerritinmedicine.anatomical_structureDisease severitylawInternal medicinebiology.proteinMedicinebusinessRespiratory tract
researchProduct

Testicular cancer and viral infections: A systematic literature review and meta-analysis

2013

In 1984, Newell and coworkers were the first to suggest that testicular cancer might have a viral etiology since it showed similar characteristics to Hodgkin's lymphoma. A systematic literature review and meta-analysis was conducted to investigate a possible association between viral infections (EBV, CMV, Parvovirus B19, HPV, and HIV) and testicular cancer. Articles published from 1985 through June 2010 were located from MEDLINE and EMBASE databases, 21 articles were finally included in the review. For infection with EBV, CMV, Parvovirus B19, and HIV the pooled OR were 4.80 (95% CI 0.98–23.54), 1.85 (95% CI 0.92–3.70), 2.86 (95% CI 0.35–23.17), and 1.79 (95% CI 1.45–2.21) respectively. No p…

medicine.medical_specialtybiologybusiness.industryParvovirusvirusesHPV infectionvirus diseasesmedicine.diseasebiology.organism_classificationViral IdentificationVirologyLymphomaInfectious DiseasesSystematic reviewVirologyMeta-analysisEpidemiologyMedicinebusinessTesticular cancerJournal of Medical Virology
researchProduct

Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal

2021

Abstract Hepatitis C virus (HCV) affects over 70 million people globally, with an estimated 399 000 HCV‐related deaths in 2016. The World Health Organization (WHO) has set a goal to eliminate HCV by 2030. Despite the availability of direct‐acting antivirals—highly effective and well‐tolerated therapies for HCV—many patients infected with HCV in Germany have not initiated treatment, including a majority of those who are aware of their positive diagnosis. Barriers to screening, diagnosis, and treatment are major factors taking many countries off track for HCV elimination by 2030. Identifying country‐specific barriers and challenges, particularly in at‐risk populations such as people who injec…

medicine.medical_specialtybusiness.industryHepatitis C virusbarriersRReviewsvirus diseasesReviewGeneral MedicineHepatitis Chigh‐risk groupsmedicine.diseasemedicine.disease_causeHepatitis CHcv eliminationWorld healthdigestive system diseasesMen who have sex with meneliminationFamily medicineGermanyMedicineMedicinebusinessGood practiceHealth Science Reports
researchProduct

Hepatitis C virus infection and global kidney health: the consensus proceedings of the International Federation of Kidney Foundations

2020

Hepatitis C virus (HCV) infection is an important cause of major morbidities including chronic liver disease, liver cancer, and acute kidney injury (AKI) as well as chronic kidney disease (CKD). HCV can affect kidney health; among CKD and AKI patients with HCV infection, the clinical outcomes are worse. The prevalence of HCV infection is exceptionally high among dialysis and kidney transplant patients throughout the globe. It is estimated that 5% to 25% or more of dialysis dependent patients are affected by chronic HCV, based on the region of the world. Almost half of all deaths in CKD patients, including HCV-infected patients, are due to cardiovascular disease, and HCV infected patients ha…

medicine.medical_specialtybusiness.industryHepatitis C virusmedicine.medical_treatmentPublic healthAcute kidney injuryvirus diseasesDiseaseurologic and male genital diseasesmedicine.disease_causemedicine.diseaseChronic liver diseaseArticledigestive system diseasesPsychiatry and Mental healthNeuropsychology and Physiological PsychologyInternal medicineAfricamedicinehepatitis C virus infectionViral hepatitisbusinesschronic kidney diseaseDialysisKidney diseaseAfrican Journal of Nephrology
researchProduct

Cardiovascular risk and liver transplantation in HIV patients. Are HIV infected liver transplant recipients at higher risk?

2021

Abstract Background Cardiovascular (CV) diseases are currently one of the main causes of morbimortality in HIV-infected patients. Similarly, LT recipients have increased prevalence of CV risk factors. Our aim was to assess whether HIV infected LT patients have an increased prevalence of CV risk factors and events (CVE) as compared to non-HIV LT patients. Methods We included LT recipients from 2004 to 2016 from a single center. HIV-infected patients were matched to 2 non-HIV controls each by sex, liver disease etiology, and date of LT. Results A total of 138 LT recipients were included (46 HIV-infected and 92 HIV-uninfected). HCV was the main etiology (85% of HIV-infected and 83% of HIV-unin…

medicine.medical_specialtybusiness.industryIncidence (epidemiology)medicine.medical_treatmentvirus diseasesLiver transplantationSingle Centermedicine.diseaseLiver diseaseInternal medicineHiv infectedmedicineEtiologyHiv patientsCumulative incidencebusinessJournal of Liver Transplantation
researchProduct

“Small Volume Resuscitation” as Treatment of Cerebral Blood Flow Disturbances and Increased ICP in Trauma and Ischemia

1996

“Small volume resuscitation” (SVR) is a promising concept for the treatment of shock and trauma patients. SVR utilizes the fast infusion of a small volume of hypertonic saline to mobilize intraendothelial and parenchymal water to expand and restitute intravascular volume. Therefore it seems warranted to also consider SVR for the treatment of disturbances of the cerebral circulation and of increased intracranial pressure (ICP). The current study uses a rabbit model of global cerebral ischemia combined with mild hemorrhage to test SVR. Somatosensory evoked potentials (SEPs) serve as a short-term outcome parameter. The data demonstrate a beneficial effect on ICP, a better reperfusion, and an i…

medicine.medical_specialtybusiness.industryIschemiavirus diseasesmedicine.diseasedigestive system diseasesHypertonic salineCerebral circulationCerebral blood flowSomatosensory evoked potentialInternal medicineShock (circulatory)medicineIntravascular volume statusCardiologymedicine.symptombusinessIntracranial pressure
researchProduct

Vaccinare per HPV: non solo le adolescenti e non solo profilassi. Review e position paper dell'Italian HPV Study Group (IHSG)

2020

HPV vaccination has been introduced in clinical practice in recent years and represents the most effective strategy of primary prevention of cervical carcinoma and of female genital preneoplastic conditions. One of the major issues of the subject is represented by vaccination coverage of the target population. Since its introduction, HPV vaccine efficacy has been progressively demonstrated also towards extragenital HPV-correlated conditions and in males too. Moreover, even subjects of older age groups or subjects who already had HPV infections have been demonstrated to received benefits from vaccination, due to improvements of their immunological response. Recently, vaccine efficacy has als…

medicine.medical_specialtybusiness.industrymedicine.medical_treatmentvirus diseasesObstetrics and GynecologyHpv vaccinationVaccine efficacyfemale genital diseases and pregnancy complicationsVaccinationInternal medicineVaccination coverageCervical carcinomamedicinePosition paperSex organbusinessAdjuvantMinerva Ginecologica
researchProduct